Samuel Sanchez
Group leader
Bladder tumours reduced by 90% using nanorobots
The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.
BIST Forum, a meeting to highlight the value of frontier research
The BIST Forum has discussed how excellent science enhances the development of society and economic growth. The event was attended by the President of the Catalan Government, the Mayor of Barcelona, the heads of the highest economic institutions and the rectors of the main universities. At the event, the new BIST IGNITE projects for multidisciplinary research were announced, three of which have the participation of IBEC.
Predoctoral researcher at the Smart Nano-Bio-Devices Research Group (Ref.: Phd_IV2_SS)
Ref: Phd_IV2_SS // Deadline 31/12/2023
Samuel Sanchez receives the Constantes y Vitales Award
IBEC researcher Samuel Sánchez has been honored with the 2023 Constantes y Vitales Award in the “Young Talent in Biomedical Research” category for his work on designing self-propelled nanorobots capable of delivering drugs within the human body. This initiative, presented by LaSexta and AXA Foundation, aims to foster biomedical research in Spain and spotlight the contributions of its scientists.
IBEC showcases its technological capabilities to foster new partnerships at BIOSPAIN
IBEC showcases its technological capabilities to foster new partnerships at BIOSPAIN. IBEC representatives actively participated in the BIOSPAIN conference, seizing the opportunity to highlight the institute’s advancements in science and technology. Over the three days of the event, they presented various aspects, ranging from basic research to the coordination of state plans and technology transfer conducted at IBEC. BIOSPAIN, a premier congress in Europe, brings together more than 850 innovative entities specializing in health, sustainable agri-food practices, and solutions against climate change.
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in … Read more
Samuel Sánchez Receives ERC Proof of Concept Grant to Target Mucinous Tumors with his Nanorobots
Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.
Samuel Sánchez awarded the BASF-ICIQ Prize for Best Entrepreneur for his spin-off Nanobots Therapeutics
Today marked the second edition of the BASF-ICIQ Innovation and Entrepreneurship Awards, which reward excellence in the field of chemistry. The biomedical company Nanobots Therapeutics S.L., led by Prof. Samuel … Read more